Frequency Therapeutics to Participate at Upcoming March Investor Conferences
February 27 2023 - 7:30AM
Business Wire
Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative
medicine company focused on developing therapeutics to activate a
person’s innate potential to restore function, today announced that
interim Chief Executive Officer and Chief Scientific Officer
Christopher Loose, Ph.D., will present at the following March
healthcare investor conferences:
43rd Annual Cowen Healthcare Conference: Dr. Loose will
participate on a panel discussion on March 8th at 12:50 p.m.
ET.
33rd Annual Oppenheimer (Virtual) Healthcare Conference:
Dr. Loose will provide a Company overview on Monday March 13th at
8:00 a.m. ET.
Live conference webcasts can be accessed on the Investors and
Media section of the Company’s website, investors.frequencytx.com.
A replay will be posted following each event.
About Frequency Therapeutics
Headquartered in Lexington, Mass., Frequency Therapeutics is
pioneering a new category in regenerative medicine that aims to
restore human function by developing therapeutics that activate a
person’s innate regenerative potential within the body through the
activation of progenitor cells. The Company’s lead preclinical
program is designed to activate oligodendrocyte precursor cells
with the goal of driving remyelination and potential functional
recovery for individuals living with multiple sclerosis. For more
information, visit www.frequencytx.com and follow Frequency on
Twitter @Frequencytx.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230227005295/en/
Investors: Carlo Tanzi, Ph.D. Kendall Investor Relations
ctanzi@kendallir.com 617-914-0008
Media: Frequency Therapeutics Email: media@frequencytx.com
Frequency Therapeutics (NASDAQ:FREQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Frequency Therapeutics (NASDAQ:FREQ)
Historical Stock Chart
From Apr 2023 to Apr 2024